Cerus Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing financial results for the three and nine months ended on that date, with common stock trading on NASDAQ:CERS.

Key Highlights

  • Product revenue: $57,714 thousand for the three months ended September 30, 2026, compared with $52,698 thousand for the same period in 2025, according to the filing.
  • Gross profit on product revenue: $30,265 thousand for Q3 2026, up from $28,140 thousand in Q3 2025, as reported in the condensed consolidated statements of operations.
  • Net loss attributable to Cerus Corporation: $(550) thousand for the three months ended September 30, 2026, and $(5,130) thousand for the nine months ended September 30, 2026.
  • Government contract revenue: $6,304 thousand in Q3 2026, compared with $7,539 thousand in Q3 2025, per the filing.
  • Total assets: $204,729 thousand as of September 30, 2026, down from $221,859 thousand as of December 31, 2025.
  • Shares outstanding: 201,954,184 shares of common stock as of October 16, 2026, per the cover page of the filing.
  • Accumulated deficit: $(1,086,285) thousand as of September 30, 2026, per the condensed consolidated balance sheet.

Cerus Corporation Financial Results for the Quarter Ended September 30, 2026

According to the filing, Cerus Corporation, a Delaware-incorporated company headquartered in Concord, California, reported product revenue of $57,714 thousand for the three months ended September 30, 2026, compared with $52,698 thousand for the corresponding period in 2025. For the nine months ended September 30, 2026, product revenue totaled $168,816 thousand, versus $148,382 thousand for the nine months ended September 30, 2025. The company also reported government contract revenue of $18,398 thousand for the nine-month period in 2026, compared with $20,837 thousand in the same period of 2025.

The filing shows that total operating expenses for the nine months ended September 30, 2026 were $107,918 thousand, consisting of research and development costs of $43,188 thousand and selling, general and administrative costs of $64,730 thousand. Cost of product revenue for the nine months was $81,125 thousand, resulting in a gross profit on product revenue of $87,691 thousand. The loss from operations for the nine-month period was $(1,829) thousand, compared with a loss from operations of $(8,040) thousand for the nine months ended September 30, 2025.

As of September 30, 2026, the company reported total liabilities of $128,367 thousand and total stockholders' equity of $76,362 thousand, including a noncontrolling interest of $661 thousand. Cash and cash equivalents stood at $16,350 thousand, with short-term investments of $40,759 thousand. The filing indicates the company is classified as an accelerated filer and is not a smaller reporting company or emerging growth company. Net loss per share attributable to Cerus Corporation for both the three-month and nine-month periods ended September 30, 2026 was $(0.00) and $(0.03), respectively, on a basic and diluted basis.

What Was Disclosed

Cerus Corporation filed a Form 10-Q for the quarterly period ended September 30, 2026, reporting product revenue, operating expenses, net losses, balance sheet position, and share count data for the three and nine months ended on that date. The filing covers unaudited condensed consolidated financial statements and related notes.